Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology

Leave a comment


News Image

“The results of the 2023 Life Sciences Digital Pathology Adoption Survey confirms that digital pathology has earned its place on the C-suite agenda across life sciences organizations,” said David West, Proscia’s CEO


PHILADELPHIA (PRWEB)

Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.

The “2023 Life Sciences Digital Pathology Adoption Survey” asked 40 senior executives from top pharmaceutical companies and leading contract research organizations (CROs) about their use of digital pathology, the benefits it has delivered, and its future impacts. The results collectively indicate a growing need to unify teams, applications, including AI, and pathology data with a modern software platform that drives all stages of R&D across the connected enterprise.

Specific findings include:


  • Executives see digital pathology as a solution to R&D’s biggest challenges. The average drug takes 10 to 15 years and costs $2.6 billion to introduce to patients.[1] It follows that improving collaboration, which leads to added efficiency and eliminates the cost of shipping glass slides among today’s increasingly distributed research teams, and streamlining operations were cited as the top two reasons for going digital (83% of respondents). More generally, 80% of respondents see digital pathology as a means of overcoming lengthy timelines, and 68% view the technology as a way to cut costs.

  • AI is already powering drug discovery and development. 82% of respondents that use digital pathology have begun to implement AI. Among them, 87% leverage image analysis applications to unlock new insights, and 65% have deployed process automation solutions that drive quality and efficiency by reducing mundane tasks. All other current digital pathology users surveyed have plans to adopt AI. Combined, these findings highlight an intensifying need for an enterprise pathology platform that incorporates a broad portfolio of AI applications into routine operations.

  • Digital pathology is opening up a new data opportunity. 55% of respondents indicated that creating data assets is a key driver of their digital pathology investment. As pathology data informs every drug brought to market and each whole slide image contains over 1 billion pixels that can shape future breakthroughs, pharmaceutical leaders recognize the potential of this new source of real world data and should now consider how to fully incorporate it into their workflows.

“Our survey confirms that digital pathology has earned its place on the C-suite agenda across life sciences organizations,” said David West, Proscia’s CEO. “These executives see its promise and must now grow their implementations to realize its full potential today and in the future with modern software. As they do, we anticipate that the enterprise pathology platform will establish itself as a new standard for bringing innovative therapies to patients.”

The “2023 Life Sciences Digital Pathology Adoption Survey” was conducted by Atheneum on Proscia’s behalf. To read all of the findings, access the full report here.

About Proscia

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and 14 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.

[1] Pharmaceutical Researchers and Manufacturers of America. (2021, September 30). Research & Development Policy Framework. PhRMA Org. Retrieved May 9, 2023, from https://phrma.org/policy-issues/Research-and-Development-Policy-Framework

Share article on social media or email:

Health

A-Alpha Bio Announces Collaboration With Gilead to Advance Next-Generation HIV Therapeutic Options

Leave a comment


We are excited to collaborate with Gilead to advance the next generation of HIV therapies, drawing on our expertise in discovering and optimizing highly cross-reactive biologics


SEATTLE (PRWEB)

A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, today announced a collaboration with Gilead Sciences, Inc. (Gilead) that aims to advance the design of human immunodeficiency virus (HIV) therapies. A-Alpha Bio will leverage its platforms to characterize binding affinities between potential therapeutic proteins and various viral protein variants that Gilead may incorporate into potential future long-acting combination HIV therapy options.

Under the collaboration, A-Alpha will apply its synthetic biology platform, AlphaSeq, to assess millions of interactions between potential therapeutic moieties and viral protein variants. The data generated by AlphaSeq will inform their machine learning (ML) platform, AlphaBind, to predict proteins that offer enhanced binding breadth and resistance to viral escape. As part of the collaboration, A-Alpha Bio will receive upfront and near-term success payments and will be eligible for development milestones and royalties if Gilead exercises its option to license novel proteins identified by A-Alpha.

HIV remains a global epidemic despite monumental scientific advances. The urgent nature of the epidemic has led to the development and implementation of therapeutics targeting all phases of the viral life cycle. Research and innovation that focuses on the development of novel HIV therapeutics will have the most significant public health impact in expanding options for all people affected by HIV.

A-Alpha Bio, the protein-protein interaction company, is uniquely suited to discover and optimize biologics with challenging binding requirements, such as broad cross-reactivity. This advantage stems from their ability to measure protein-protein interactions at a library-on-library scale with their AlphaSeq platform and their ability to explore an enormous sequence space computationally with their AlphaBind platform. “We are excited to collaborate with Gilead to advance the next generation of HIV therapies, drawing on our expertise in discovering and optimizing highly cross-reactive biologics,” said David Younger, CEO and Co-founder of A-Alpha Bio. “Gilead is a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research for more than three decades. We are confident that the insights we aim to provide through our platforms will support Gilead’s continuous pursuit of scientific discovery to provide solutions for the evolving needs of people affected by HIV around the world.”

About A-Alpha Bio

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

The company’s AlphaSeq platform applies synthetic biology to experimentally measure millions of protein-protein interaction affinities simultaneously. Protein binding data is incorporated into the company’s AlphaBind platform to train machine learning models that predict binding from sequence. A-Alpha Bio uses both platforms to discover and optimize high-impact therapeutics for their own pipeline and in partnership with industry leaders.

A-Alpha Bio is based in Seattle and was founded in 2017 at the University of Washington’s Institute for Protein Design and Center for Synthetic Biology. To learn more, please visit: https://www.aalphabio.com/.

Share article on social media or email:

Health

Unitek EMT Joins the National Awareness “Stop the Bleed” Campaign

Leave a comment


Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College.

Through our boot camp, graduates will acquire essential bleeding control skills, earn official certification, and become empowered first responders.


TEMPE, Ariz. (PRWEB)

Unitek Learning is thrilled to announce the integration of the “Stop the Bleed” training course into their EMT program. Beginning in July of 2023, this lifesaving class will equip Unitek EMT students with critical skills to act quickly and effectively in bleeding emergencies. Aspiring EMTs will have the opportunity to enhance their education and make a real impact during emergencies.

“This is thrilling news for our team and the community,” said Jessica Gonzalez, Director of the EMT Program. “Through our boot camp, graduates will acquire essential bleeding control skills, earn official certification, and become empowered first responders.”

Developed by the American College of Surgeons, this training course contains three essential techniques to save lives: applying pressure, packing wounds, and correctly applying a tourniquet. Other benefits include experienced instructors who provide live, in-person training, helping to ensure that students master the skills they need to make a life-or-death difference in emergencies.

“At Unitek, we are dedicated to preparing the next generation of top-notch EMTs and helping them with their ongoing success,” said Janis Paulson, Chief Executive Officer at Unitek Learning. “Because our Boot Camp prepares EMTs in just 14 days, Unitek EMT is uniquely qualified to help combat shortages and replenish the workforce. Now we hope to save more lives through the ‘Stop the Bleed’ campaign.”

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College. Unitek programs teach the clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in healthcare and nursing.

Share article on social media or email:

Health

Tapcheck and WellSky Partner to Offer Financial Wellness Benefits, Including Earned Wage Access, Across the U.S.

Leave a comment


News Image

When providers want to ensure they’re taking care of caregivers as well as they are patients, they turn to Tapcheck, and through this partnership with WellSky, we’re giving caregivers greater financial control and improving agency profitability and performance.


TARZANA, Calif. (PRWEB)

Tapcheck, a leading provider of employee financial wellness solutions with the most precise on-demand pay offering available, has partnered with WellSky®, a leading health and community care technology company. Tapcheck and WellSky have integrated Tapcheck’s financial wellness benefits platform into WellSky Personal Care software. This integration will allow WellSky’s clients to enable early or earned wage access (EWA) for the 600,000+ caregivers they collectively employ, driving profitability and business performance improvement through increased employee productivity, attendance, retention and recruiting.

“We’re excited to partner with WellSky to bring our financial wellness platform to Personal Care customers,” said Ron Gaver, Tapcheck’s CEO. ” When providers want to ensure they’re taking care of caregivers as well as they are patients, they turn to Tapcheck, and through this partnership with WellSky, we’re giving caregivers greater financial control and improving agency profitability and performance.”

WellSky Personal Care is a leading software platform that provides comprehensive solutions for private duty home care agencies. The platform includes a caregiver scheduling and matching system, integrated point-of-care documentation, and family engagement tools. Caregivers using WellSky Personal Care provide over 80 million hours of care annually.

“Integrating Tapcheck’s platform into WellSky Personal Care is another step forward in providing a comprehensive solution for our home care agencies,” said Wes Little, Chief Analytics Officer and General Manager at WellSky. “We’re pleased to partner with Tapcheck to help caregivers alleviate financial stress and improve on-the-job performance as well as give our clients improved tools for recruiting and retaining top employees.”

Both WellSky and Tapcheck are preferred vendors for Right at Home, a recognized, national brand and franchisor within the home care services industry. “Right at Home is committed to working with vendors who help our franchisees operate at peak performance,” said Caeli Feller, Business Development Manager at Right at Home. “WellSky and Tapcheck have been impactful additions to our brand, and we’re excited to see them working together to help our agencies succeed.”

Tapcheck’s financial wellness platform provides a range of benefits for employees and employers alike. The platform enables employees to access earned wages in real-time – also known as Earned Wage Access – in addition to content to improve financial literacy and an optional Tapcheck debit Mastercard. Tapcheck was started by Ron and Kayling Gaver after witnessing the positive impact that financial wellness programs had on their employees and business performance.

ABOUT TAPCHECK

Tapcheck is a financial wellness company that offers a suite of benefits for employees, including the market’s highest precision on-demand pay product, also known as Earned Wage Access (EWA). Available at no cost to employers, Tapcheck enables employees to safely access a portion of their paycheck, for completed shifts, ahead of the next payday. Tapcheck integrates with 200+ payroll and time and labor management systems to seamlessly enable its EWA solution. Employers who incorporate on-demand pay into their employee benefits packages find it to be a cost-effective way to distinguish their company from competitors, reduce turnover rates, and provide the financial flexibility that employees want. For more information, visit https://www.tapcheck.com and follow us on LinkedIn, Twitter, and Facebook.

ABOUT WELLSKY

WellSky is a leading provider of software solutions for post-acute and community care providers, including home health, hospice, personal care, and rehab facilities. The company offers a range of software solutions, including clinical, financial, and operational software, to help providers improve patient outcomes and increase efficiency.

Share article on social media or email:

Health

Rosarium Health™ Closes $1.7M Pre-Seed Round to Bring Barrier-Free Housing to People with Mobility Challenges

Leave a comment


Creating more accessible housing not only helps older individuals and those with mobility issues maintain their independence and dignity but also greatly reduces healthcare costs.


HOUSTON (PRWEB)

Rosarium Health, a Houston-based integrated service provider network that connects people with service providers to deliver home modifications for accessibility purposes, has closed its pre-seed funding round, generating $1.7M in investments.

The pre-seed round was led by Primetime Partners and Rock Health Capital. Tundra Ventures, Flare Capital Partners, Sequential Ventures, Groundbreak Ventures, and several healthcare operating angel investors also participated in the round.

The close of the funding round is another win for the growing start-up, which was selected as a 2022 winner of the inaugural National Institute on Aging Start-Up Challenge and Accelerator: Fostering Entrepreneurial Diversity.

With the pre-seed round of funding complete, Rosarium Health plans to further develop its marketplace platform to serve hospital systems and provider organizations in addition to individual households. The team will develop its enterprise product and begin to partner with accountable care organizations, community-based organizations, and payors. The planned partnerships aim to reduce readmission rates, improve quality performance, and enable beneficiaries to live as independently as possible.

“Our homes are our sanctuaries, but for people with mobility issues, inaccessible spaces can cause frustration, unsafe living conditions, and a loss of dignity,” said Cameron Carter, CEO and co-founder of Rosarium Health. “Interest in creating accessible living spaces is growing among everyday people, service providers, and professional investors. And thanks to the contributions of our new partners, Rosarium Health is in a great position to scale investments into natural capital and achieve our expansion goals and mission of accessibility, always.”

Rosarium Health improves health outcomes and quality performance by improving household accessibility. The Rosarium Health platform connects healthcare professionals and home remodeling companies to households needing accessible home modifications. The company serves individuals across the age span, whether children on Managed Medicaid plans, seniors on D-SNP products, or anyone who wants to age with dignity.

The company aims to achieve its mission of accessibility by imagining housing as a tenet of healthcare, offering high-quality, affordable, and efficacious solutions. Whether a household needs to be assessed or an accessible home modification implemented, Rosarium Health is available to its clients at scale.

And as the US population continues to age, with 1 in 6 households currently led by an individual over the age of 65 and expectations that these numbers will continue to increase over the next two decades. Rosarium Health sees an opportunity to help older individuals retain their dignity while also reducing healthcare costs.

“Creating more accessible housing not only helps older individuals and those with mobility issues maintain their independence and dignity but also greatly reduces healthcare costs,” said Carter. “Even modest investments in creating accessible spaces can reduce total cost of care associated with avoidable emergency room visits, inpatient stays, and physical therapy. And the improvements in the individual’s mental health are notable as well.”

After finding success in the Houston market, Rosarium Health has its eyes set on national expansion, starting with scaling throughout Texas. In addition to geographic expansion, Rosarium Health aspires to create partnerships with industry professionals such as non-profits and contractors that are also committed to creating a more accessible world.

About Rosarium Health

Rosarium Health™ is a platform that connects service providers (home contractors and occupational therapists) to clients to complete accessible home assessments and accessible home modifications at a client’s primary home, rental property, or their business. The platform strives to create a barrier-free world for people of all ages. To learn more about Rosarium Health, visit rosariumhealth.com.

Share article on social media or email:

Health

Paul Brodrick debuts as a published author with the release of ‘Cancer Mentality’

Leave a comment


News Image


PERTH, Australia (PRWEB)

All his life, Paul Brodrick thought that he was living healthily, deliberately. But, after a having cancer diagnosis and a bowel tumor removed, he found himself reassessing his actions and choices. He now shares this journey within the pages of “Cancer Mentality: The Cure for Cancer is in the Mind – Heal your Attitudes and Beliefs” (published by Balboa Press AU).

In this book, the author reveals what it was like to be diagnosed with cancer, how he dealt with the fear of defective genes, and how he learned to choose his own prognosis for a cancer-free future. Here, Brodrick weaves his story with cutting-edge mind-body connection science and metaphysical approaches, explaining how they played a role in his recovery and wellness. The overall theme is that cancer (and all major illness) is treatable by a combination of medical science and learning to understand the connection between emotions, beliefs, and people’s reactions to life. Healing, the author firmly believes, begins with rewriting one’s long-held attitudes and beliefs.

“I learned that all illness begins in our attitudes and beliefs, and is repairable through the mind too,” Brodrick states. “The story shows my process of learning how to transform my formerly cancer-promoting mentality into a health-promoting one.”

When asked what he wants readers to take away from the book, the author responds, “That life and health are what we make of them; that we all have the power to sicken ourselves and to heal ourselves; that we are so lucky to have incredible technology to help us, and now this technology is explaining the way our thoughts and beliefs impact our physiology.”

Visit https://www.balboapress.com/en-au/bookstore/bookdetails/847161-cancer-mentality to get a copy.

“Cancer Mentality: The Cure for Cancer is in the Mind – Heal your Attitudes and Beliefs”

By Paul Brodrick

Softcover | 5.5 x 8.5in | 296 pages | ISBN 9781982296711

E-Book | 296 pages | ISBN 9781982296728

Available at Amazon and Barnes & Noble

About the Author

Perennially interested in how things work, Paul Brodrick lives fully. Curiosity and the ongoing search for love took him from motorsport-mad mechanic to spiritual cult acolyte, to working-holiday tree-hugger, then to marriage-two-kids-two-mortgages-and-divorce. From there, raising those two kids as a single dad, serial house renovating, and almost 20 years running his own business taught him so much about life. The stressful failure of that business and near bankruptcy precipitated emergency surgery for a tumor that was strangling his colon; cancer rocked Brodrick’s world despite thinking he was living healthily. This instigated a complete change in his perspective on what is healthy and how to live a good, long life; the book “Cancer Mentality” is the result of these changes.

Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au or call 1-800-844-925.

Share article on social media or email:

Health

Celebrity Chefs and Students Unite to Promote Food Education in an Epic Community Top Chef NYC Competition

Leave a comment



NEW YORK (PRWEB)

Promoting the importance of food education, students and renowned New York chefs came together in an exhilarating display of culinary talent at the Community Top Chef NYC competition on June 8th. The cooking competition was organized by Common Threads along with hosting sponsor Raymond James Financial, and paired four students from Frederick Douglass Academy in Brooklyn with celebrated chefs Anita Lo, Camari Mick, Edie Ugot, and Cosme Aguilar. They worked in the kitchen to create incredible dishes, with the winning culinary creation being Chana Masala. Common Threads’ healthy and kid-friendly recipes can be found here.

The event comes on the heels of NYC’s unveiling of a comprehensive nutrition roadmap that prioritizes food education in their public schools. Common Threads, a national nonprofit that supports food as medicine, inspires communities to embrace healthy cooking, healthy eating and the celebration of culture by providing children, families and educators with hands-on cooking and nutrition education classes. The program’s initiatives have been implemented in 72 schools in New York City, enriching the lives of 12,464 students through comprehensive nutrition education.

The four teams created top-notch dishes in lightning speed using fresh produce and quality ingredients. The event, which took place at Raymond James Financial’s headquarters on Park Ave, was emceed by TV host and actor Adam Richman. Judges included chefs Gail Simmons and Ayesha Nurdjaja who selected the winner based on taste, presentation, and overall creativity.

“The Community Top Chef NYC competition shines a spotlight on the unifying power of food,” said Linda Novick O’Keefe, Common Threads Co-Founder and CEO. “Every event we organize, every dish that is created, and every connection that is formed propels us towards a healthier, more inclusive world. We are profoundly grateful for the passion and commitment demonstrated by those who participated in and supported this event.”

The cook-off challenge resulted in Chef Camari Mick and student Sakera Mormon-Hall claiming the title of Common Threads Community Top Chef NYC. Attendees of the invite-only challenge enjoyed lite bites and refreshments.

“It was exciting to cook alongside world-famous chefs and to see how they work in action. The competition also teaches us about different ingredients and making healthy eating decisions,” said student Kaylee Gomez-Lopez.

Approximately 74% of NYC public school students come from families living at or below the poverty line, struggling for access to wholesome foods or able to use healthy cooking habits. Common Threads has partnered with NYC public schools for eight years and has taught over 65,000 students in their elementary and middle schools, teaching hands-on cooking and snack-making, the basics of nutrition, and the importance of making nutritious choices in and after-school.

Notable participant chefs included:

  • Chef Anita Lo, Culinary Host of Tour De Forks

  • Chef Camari Mick, Executive Pastry Chef at The Musket Room

  • Chef Edie Ugot, Co-founder and Culinary Director of Sidney’s Five

  • Chef Cosme Aguilar, Executive Chef at Casa Enrique

  • Chef Ayesha Nurdjaja, Executive Chef and Partner at Shukette NYC & Shuka NYC

  • Chef Gail Simmons, Culinary expert, food writer, and Bravo’s Top Chef Judge

“The Common Threads program is a beacon of light when it comes to teaching students and the community about the power of nutrition and making healthful choices,” said Chef Anita Lo. “It is a privilege to be involved in such a meaningful initiative that empowers individuals to embrace healthy cooking, healthy eating, and the celebration of culture. Together, we can make a lasting impact on the well-being of our communities.”

“Prioritizing food education and promoting healthful choices among our students is a key focus for us in New York City,” said Kate MacKenzie, Executive Director of the Mayor’s Office of Food Policy. “The inspirational collaboration between our city’s students and recognized chefs, orchestrated by Common Threads, underlines the remarkable impact of this focus. These meaningful partnerships exemplify our citywide commitment to fostering healthier futures for our youth.”

# # #

About Common Threads

Common Threads has been providing children and families with cooking and nutrition education to encourage healthy eating habits that contribute to wellness. Founded in 2003, the national non-profit organization focuses on equipping under-resourced communities with information to make affordable, nutritious, and appealing food choices wherever they live, work, learn, and play. Because food is rooted in culture and tradition, Common Threads promotes diversity in all lessons and recipes, encouraging participants to celebrate their culture. Common Threads currently operates in 10 major U.S. cities (Los Angeles, Chicago, Miami, New York, Erie, Pittsburgh, Austin, Dallas, Fort Worth, and El Paso). During the 2021-22 school year and summer, Common Threads provided hands-on cooking skills and nutrition education to 48,000 students and adults, worked with 310 schools and partners, and served 263,000 healthy meals and snacks. For more information, visit CommonThreads.org.

Share article on social media or email:

Health

Homecare Homebase First EHR Vendor to Achieve Dual CHAP Verified Status

Leave a comment


HCHB CHAP Dual Verified Press Release

Our position as the first software platform to be awarded dual CHAP verification status further illustrates our dedication to helping HCHB customers provide the best possible care for patients in the home.


DALLAS (PRWEB)

Homecare Homebase (HCHB), is proud to announce that our home-based care software solution is the first to achieve dual verification status from Community Health Accreditation Partner, (CHAP). A non-profit accrediting body for home and community-based healthcare organizations, CHAP is approved by CMS and is a recognized leader in accreditation for both home health and hospice.

CHAP Verified status is granted to tools and resources used by community-based care providers that, through rigorous inspection, show no roadblocks to executing the CHAP Standards of Excellence and innovate to improve the delivery of high-quality care. To confirm HCHB’s verification, CHAP conducted two separate product surveys of the Homecare Homebase platform, taking into account the requirements for both Age-Friendly Care at Home Certification and CHAP accreditation. As part of the Age-Friendly Care at Home verification process, HCHB’s product team also went above and beyond to create a guide to assist Homecare Homebase customers seeking Age-Friendly Care at Home Certification.

Teresa Harbour, Chief Operating Officer for CHAP shared her perspective on HCHB’s dual verification: “We have been excited to work closely with Homecare Homebase on both CHAP verification projects and look forward to collaborating as more HCHB home health and hospice customers pursue Age-Friendly Care at Home Certification and CHAP accreditation.”    

“HCHB and CHAP share a commitment to enabling quality patient care and innovation” stated Scott Decker, CEO of Homecare Homebase. “Our position as the first software platform to be awarded dual CHAP verification status further illustrates our dedication to helping HCHB customers provide the best possible care for patients in the home.”

About Homecare Homebase, LLC

Homecare Homebase is a Dallas-based software leader offering hosted, cloud-based solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for home-based care agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting, and improved revenue cycle management. Founded by industry veterans in 1999, HCHB empowers over 200,000 users to service more than 800,000 patients daily, resulting in over one hundred million visits per year. The company is part of the Hearst Health network. For more information visit http://www.hchb.com or call us toll-free at 1- 866-535-HCHB (4242).

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

About Community Health Accreditation Partner (CHAP)

CHAP is an independent, nonprofit organization accrediting providers of home and community-based care. Founded in 1965, CHAP was first to recognize the need for and value of home and community-based care standards and accreditation. As a Centers for Medicare & Medicaid Services (CMS)–approved accrediting organization, CHAP surveys organizations providing home health, hospice, and home medical equipment services to establish if Medicare Conditions of Participation and DMEPOS Quality Standard are met and recommend certification to CMS. CHAP’s purpose is to partner with organizations nationwide to advance quality in the delivery of care and services in the home and community.

###

Media Contacts

For Homecare Homebase:

Liz LeGrande

llegrande@hchb.com

For CHAP:

Dan McPhilemy

202-467-1709

Dan.mcphilmy@chapinc.org

Share article on social media or email:



Health

Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Gastrointestinal Cancer

Leave a comment


News Image

Immunotherapy has transformed the standard of care for many gastrointestinal cancers, improving treatment responses and offering some patients prolonged survival.


MILWAUKEE (PRWEB)

The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication of a new clinical practice guideline (CPG) focused on immunotherapy for the treatment of gastrointestinal cancer.

The manuscript, “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer”, was published in the Journal for ImmunoTherapy of Cancer (JITC), SITC’s peer-reviewed, open-access online journal.

“Immunotherapy has transformed the standard of care for many gastrointestinal cancers, improving treatment responses and offering some patients prolonged survival,” said Ronan Kelly, MB BCh, MBA, co-chair of the SITC Gastrointestinal Cancer Immunotherapy Guideline Expert Panel. “The efficacy of immunotherapy in gastrointestinal cancers, however, is very much dependent on a comlex interplay of biomarker status, histology, and the tumor site of origin.”

Although ICI therapy has improved outcomes for many patients with GI cancer, biomarker-negative disease remains unresponsive to standard immunotherapy combinations, with diseases such as microsatellite stable colon cancer remaining a leading cause of cancer-related death worldwide.

“Immunotherapy has made a tremendous positive impact on the treatment of patients with MSI-H/dMMR colorectal cancers in the metastatic setting, with exciting developments emerging in the neoadjuvant setting,” said Dung Le, MD, co-chair of the SITC Gastrointestinal Cancer Immunotherapy Guideline Expert Panel.

Using ICIs in gastrointestinal cancer requires a highly nuanced consideration of biomarker positivity, histology, and the anatomical site of cancer origin. To support clinicians in shared decision-making with their patients, the Gastrointestinal Cancer Immunotherapy Guideline Expert Panel developed evidence- and consensus-based recommendations on topics including selection of appropriate immunotherapeutic regimens, biomarkers, and patient education and quality of life considerations.

Abridged versions of the guideline highlighting key information from the publication will be available in SITC’s CPG Mobile App, along with interactive tools and tables to support clinical decision-making.

“The SITC clinical practice guidelines offer practical guidance on the use of immunotherapy based on a critical review of available data and years of collective experience from SITC’s distinguished expert panelists,” said SITC President Leisha Emens, MD, PhD. “The SITC CPG Mobile App delivers high-yield immunotherapy recommendations, algorithms, and interactive tools in a convenient easy-to-use format for busy clinicians.”

In addition to the guideline, SITC will be also offering free live webinars and on-demand modules hosted on the SITC website focusing on topics within this guideline and providing attendees the opportunity to ask questions of expert faculty:


  • Practical Management Pearls – SITC CPG Webinar

  • Case Studies – SITC CPG Webinar

The dates and times of the webinars will be available soon on this web page.

Click here to view past SITC Cancer Immunotherapy Guidelines webinars available free and on-demand.

About SITC’s Guidelines

The SITC Cancer Immunotherapy Guidelines Program is a collection of clinical practice guidelines (CPGs) developed by multidisciplinary panels of experts who draw from practical experience as well as evidence in the published literature and clinical trial data to provide recommendations for clinicians on how on how and when to use immunotherapy to help improve outcomes for patients with cancer. SITC’s guidelines provide recommendations on topics including selection of appropriate immunotherapy treatments, toxicity management, biomarkers, and considerations for patient quality of life. SITC’s expanding catalogue of CPGs spans disease-state specific guidelines for several solid tumors, hematologic malignancies, and toxicity-specific guidelines to assist clinicians with the management of immune-related adverse events. You may access the entire series of CPGs in the Journal for ImmunoTherapy of Cancer (JITC), the society’s open access, peer-reviewed online journal, or in the CPG Mobile App.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings, and other resources at sitcancer.org and follow us on Twitter, LinkedIn and YouTube.

About JITC

The Journal for ImmunoTherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of SITC. The journal publishes high-quality articles on all aspects of tumor immunology and cancer immunotherapy on subjects across the basic science-translational-clinical spectrum. JITC publishes original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal editors. These articles, freely accessible at jitc.bmj.com, make JITC the leading forum for tumor immunology and cancer immunotherapy research. Follow JITC on Twitter @jitcancer.

Share article on social media or email: